Alere Inc., formerly Inverness Medical Innovations, Inc., provides diagnosis, monitoring and health management solutions. The Company’s products and services, as well as its new product development efforts, focus on cardiology, women’s health, infectious disease, oncology and toxicology. Its operating segments include professional diagnostics, health management and consumer diagnostics. On January 15, 2010, the Company completed the sale of its vitamins and nutritional supplements business. On February 17, 2010, it acquired Alere Toxicology Services (Alere Toxicology). On February 8, 2010, it acquired a 61.92% ownership interest in Standard Diagnostics. On March 11, 2010, it acquired United Kingdom research and development operation. On August 16, 2010, the Company acquired Diagnostixx of California, Corp. In November 2010, the Company acquired of AdnaGen AG (AdnaGen). In November 2011, it acquired Arriva Medical.